Browsing NTNU Open by Author "Smeland, Knut Bjøro"
Now showing items 1-10 of 10
-
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin’s lymphoma; symptom burden and quality of life
Eikeland, Siri A.; Smeland, Knut Bjøro; Mols, Floortje; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander (Peer reviewed; Journal article, 2021)Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of Hodgkin’s lymphoma (HL) treatment. We aimed to describe the prevalence of CIPN associated symptoms in long-term HL survivors ... -
Chronic fatigue in long-term survivors of Hodgkin’s lymphoma after contemporary risk-adapted treatment
Eikeland, Siri Asheim; Smeland, Knut Bjøro; Simensen, Victoria C; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Kiserud, Cecilie E.; Fosså, Alexander (Peer reviewed; Journal article, 2023)Background Chronic fatigue (CF), substantial fatigue for ≥ six months, can manifest as a late effect (LE) after cancer treatment, and may affect several aspects of life. In a Norwegian cohort of Hodgkin’s lymphoma ... -
Chronic fatigue is highly prevalent in survivors of autologous stem cell transplantation and associated with IL-6, neuroticism, cardiorespiratory fitness, and obesity
Smeland, Knut Bjøro; Loge, Jon Håvard; Aass, Hans Christian Dalsbotten; Aspelin, Trude; Bersvendsen, Hanne Skjerven; Bolstad, Nils; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein; Fosså, Alexander; Holte, Harald; Lund, May-Brith; Murbræch, Klaus; Reinertsen, Kristin Valborg; Stenehjem, Jo Steinson; Kiserud, Cecilie E. (Journal article; Peer reviewed, 2018) -
Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Smeland, Knut Bjøro; Wilsgaard, Tom; Kiserud, Cecilie E. (Journal article; Peer reviewed, 2019)Introduction: High-dose therapy with autologous stem cell transplantation (HD-ASCT) is associated with an increased risk of late effects. Our aim was to assess lifestyle behavior and factors associated with unhealthy ... -
Long-term cardiac effects of modern treatment for Hodgkin’s lymphoma
Bjerring, Anders W.; Smeland, Knut Bjøro; Stokke, Thomas Muri; Haugaa, Kristina Ingrid Helena Hermann; Holte, Espen; Rösner, Assami; Kiserud, Cecilie E.; Edvardsen, Thor; Sarvari, Sebastian (Journal article; Peer reviewed, 2024)Background Hodgkin’s lymphoma (HL) is a hematological malignancy that affects both children and young adults. Traditional treatment is associated with a life-time prevalence of cardiac disease exceeding 50%. In the late ... -
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
Hernæs, Kjersti Helene; Smeland, Knut Bjøro; Fagerli, Unn-Merete; Kiserud, Cecilie E. (Peer reviewed; Journal article, 2021)Background This study describes post-treatment work patterns in lymphoma survivors treated with high-dose chemotherapy with autologous stem-cell transplantation (HDT-ASCT). It aims to identify determinants for labour force ... -
Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
Bersvendsen, Hanne Skjerven; Haugnes, Hege Sagstuen; Dahl, Alv A; Fagerli, Unn-Merete; Fluge, Øystein; Holte, Harald; Seland, Mette; Wilsgaard, Tom; Smeland, Knut Bjøro; Kiserud, Cecilie E. (Journal article; Peer reviewed, 2019)Reduced sexual function may have negative implications on health related quality of life among lymphoma survivors. A national cross-sectional study among long-term lymphoma survivors after high-dose therapy with autologous ... -
Survivors' knowledge of their diagnosis, treatment and possible late adverse effects after autologous stem cell transplantation for lymphoma
Simensen, Victoria C.; Smeland, Knut Bjøro; Kiserud, Cecilie E.; Dahl, Alv A; Bersvendsen, Hanne Skjerven; Fluge, Øystein; Fagerli, Unn-Merete; Fosså, Alexander (Journal article; Peer reviewed, 2019)Purpose: Lymphoma survivors after high dose therapy with autologous stem cell therapy (HD-ASCT) are at high risk for late adverse effects (AEs). Information patients receive and collect throughout their cancer trajectory ... -
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
Smeland, Knut Bjøro; Holte, Harald; Fagerli, Unn-Merete; Bersvendsen, Hanne Skjerven; Hjermstad, Marianne Jensen; Loge, Jon Håvard; Murbræch, Klaus; Linnsund, Marianne Dahl; Fluge, Øystein; Stenehjem, Jo Steinson; Samersaw-Lund, May Brit; Kvaløy, Stein Olav; Kiserud, Cecilie E. (Peer reviewed; Journal article, 2022)Lymphoma survivors after high-dose therapy with autologous stem-cell transplant (HDT-ASCT) are at risk of several late effects, which might impair their health-related quality of life (HRQoL). We assessed the total late ... -
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects
Dahl, Alv A; Smeland, Knut Bjøro; Eikeland, Siri Asheim; Fagerli, Unn Merete; Bersvendsen, Hanne Skjerven; Fosså, Alexander; Kiserud, Cecilie E. (Peer reviewed; Journal article, 2023)Purpose We studied work-related issues in long-term survivors of Hodgkin lymphoma [HLSs] who had undergone treatment according to contemporary stage risk-adapted approaches. At survey, work changes and problems since ...